Oscar Health, Inc. (NYSE:OSCR) Receives Average Recommendation of “Hold” from Analysts

Oscar Health, Inc. (NYSE:OSCR) has earned a consensus rating of “Hold” from the nine research firms that are covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $21.56.

Several research analysts have commented on OSCR shares. Jefferies Financial Group began coverage on Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price for the company. Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and decreased their target price for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th.

Oscar Health Trading Up 0.1 %

OSCR opened at $14.72 on Thursday. The company has a 50-day simple moving average of $15.01 and a 200 day simple moving average of $16.83. The stock has a market capitalization of $3.64 billion, a price-to-earnings ratio of -735.38, a P/E/G ratio of 0.50 and a beta of 1.73. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health has a twelve month low of $13.05 and a twelve month high of $23.79.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Analysts predict that Oscar Health will post 0.91 EPS for the current fiscal year.

Insider Activity at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 6,516 shares of the company’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $117,809.28. Following the sale, the insider now owns 81,962 shares of the company’s stock, valued at approximately $1,481,872.96. This represents a 7.36 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Vice Chairman Joshua Kushner acquired 358,619 shares of the stock in a transaction dated Wednesday, November 13th. The stock was acquired at an average cost of $13.74 per share, with a total value of $4,927,425.06. Following the completion of the transaction, the insider now owns 5,810,700 shares in the company, valued at approximately $79,839,018. This represents a 6.58 % increase in their position. The disclosure for this purchase can be found here. Insiders sold 103,610 shares of company stock worth $1,847,519 over the last three months. Company insiders own 25.11% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

Several institutional investors have recently added to or reduced their stakes in OSCR. Hennessy Advisors Inc. lifted its position in shares of Oscar Health by 550.3% during the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock valued at $56,292,000 after acquiring an additional 3,544,300 shares during the period. Westfield Capital Management Co. LP acquired a new stake in shares of Oscar Health in the 3rd quarter valued at about $27,452,000. JPMorgan Chase & Co. increased its position in Oscar Health by 68.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company’s stock valued at $48,977,000 after buying an additional 938,742 shares in the last quarter. Soros Fund Management LLC acquired a new position in Oscar Health during the 3rd quarter worth approximately $12,726,000. Finally, Raymond James Financial Inc. acquired a new stake in Oscar Health in the fourth quarter valued at approximately $6,613,000. 75.70% of the stock is owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.